Kevin W. Freeman

1.4k total citations
17 papers, 1.1k citations indexed

About

Kevin W. Freeman is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Kevin W. Freeman has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Neurology and 6 papers in Cancer Research. Recurrent topics in Kevin W. Freeman's work include Neuroblastoma Research and Treatments (7 papers), Fibroblast Growth Factor Research (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Kevin W. Freeman is often cited by papers focused on Neuroblastoma Research and Treatments (7 papers), Fibroblast Growth Factor Research (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Kevin W. Freeman collaborates with scholars based in United States, South Africa and United Kingdom. Kevin W. Freeman's co-authors include David M. Spencer, Rama Gangula, Jeffrey M. Rosen, Michael Ittmann, Bryan E. Welm, Norman M. Greenberg, L. E. Peterson, Rile Li, Fen Wang and Yongyou Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Kevin W. Freeman

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin W. Freeman United States	14	843	271	177	160	153	17	1.1k
Sonia Pagliardini Italy	17	610 0.7×	312 1.2×	133 0.8×	114 0.7×	100 0.7×	25	988
Satoko Ito Japan	21	779 0.9×	234 0.9×	216 1.2×	94 0.6×	217 1.4×	47	1.1k
Emily E. Bosco United States	12	654 0.8×	463 1.7×	207 1.2×	157 1.0×	229 1.5×	21	1.1k
Paolo Salerno Italy	16	667 0.8×	410 1.5×	254 1.4×	93 0.6×	120 0.8×	31	1.1k
María Élida Scassa Argentina	17	591 0.7×	223 0.8×	139 0.8×	65 0.4×	90 0.6×	36	881
Andrea M. Griesinger United States	17	759 0.9×	300 1.1×	196 1.1×	139 0.9×	79 0.5×	37	1.3k
Aparna Gupta United States	14	460 0.5×	170 0.6×	104 0.6×	296 1.9×	144 0.9×	19	778
Ellen Margrethe Haugsten Norway	19	1.2k 1.4×	227 0.8×	192 1.1×	131 0.8×	393 2.6×	31	1.5k
Lily Yen Canada	17	861 1.0×	639 2.4×	184 1.0×	109 0.7×	122 0.8×	18	1.3k

Countries citing papers authored by Kevin W. Freeman

Since Specialization

Citations

This map shows the geographic impact of Kevin W. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin W. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin W. Freeman more than expected).

Fields of papers citing papers by Kevin W. Freeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin W. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin W. Freeman. The network helps show where Kevin W. Freeman may publish in the future.

Co-authorship network of co-authors of Kevin W. Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin W. Freeman. A scholar is included among the top collaborators of Kevin W. Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin W. Freeman. Kevin W. Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Olsen, Rachelle R., et al.. (2024). Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting MYC activity. Molecular Oncology. 19(3). 808–824. 1 indexed citations

Landesman, Yosef, Bruce Pawel, Stephen R. Master, et al.. (2021). XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB. Translational Oncology. 14(8). 101114–101114. 20 indexed citations

Freeman, Kevin W., et al.. (2021). Therapeutically targeting oncogenic CRCs facilitates induced differentiation of NB by RA and the BET bromodomain inhibitor. Molecular Therapy — Oncolytics. 23. 181–191. 10 indexed citations

García-López, Jesús, Joel Otero, Rachelle R. Olsen, et al.. (2020). Large 1p36 Deletions Affecting Arid1a Locus Facilitate Mycn-Driven Oncogenesis in Neuroblastoma. Cell Reports. 30(2). 454–464.e5. 23 indexed citations

García-López, Jesús, et al.. (2020). Abstract B30: ARID1A is a haploinsufficient tumor suppressor for N-Myc transformation of neural crest cells. Cancer Research. 80(14_Supplement). B30–B30. 1 indexed citations

Olsen, Rachelle R., Joel Otero, Jesús García-López, et al.. (2017). MYCN induces neuroblastoma in primary neural crest cells. Oncogene. 36(35). 5075–5082. 69 indexed citations

Olsen, Rachelle R., et al.. (2015). Antagonizing Bcl-2 Family Members Sensitizes Neuroblastoma and Ewing’s Sarcoma to an Inhibitor of Glutamine Metabolism. PLoS ONE. 10(1). e0116998–e0116998. 13 indexed citations

Freeman, Kevin W., Brian R. Bowman, & Bruce R. Zetter. (2010). Regenerative protein thymosin β‐4 is a novel regulator of purinergic signaling. The FASEB Journal. 25(3). 907–915. 60 indexed citations

Finlayson, Alexander & Kevin W. Freeman. (2009). A Cell Motility Screen Reveals Role for MARCKS-Related Protein in Adherens Junction Formation and Tumorigenesis. PLoS ONE. 4(11). e7833–e7833. 32 indexed citations

10.

Winter, Scott F., et al.. (2007). Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2. Oncogene. 26(34). 4897–4907. 38 indexed citations

11.

Gangula, Rama, Kevin W. Freeman, Rile Li, et al.. (2007). Inducible FGFR-1 Activation Leads to Irreversible Prostate Adenocarcinoma and an Epithelial-to-Mesenchymal Transition. Cancer Cell. 12(6). 559–571. 231 indexed citations

12.

Freeman, Kevin W., Rama Gangula, Bryan E. Welm, et al.. (2003). Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.. PubMed. 63(19). 6237–43. 68 indexed citations

13.

Pownall, Mary Elizabeth, Bryan E. Welm, Kevin W. Freeman, et al.. (2003). An inducible system for the study of FGF signalling in early amphibian development. Developmental Biology. 256(1). 90–100. 34 indexed citations

14.

Freeman, Kevin W., Bryan E. Welm, Rama Gangula, et al.. (2003). Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice.. PubMed. 63(23). 8256–63. 69 indexed citations

15.

Welm, Bryan E., et al.. (2002). Inducible dimerization of FGFR1. The Journal of Cell Biology. 157(4). 703–714. 122 indexed citations

16.

Fan, L.-W., et al.. (1999). Improved Artificial Death Switches Based on Caspases and FADD. Human Gene Therapy. 10(14). 2273–2285. 98 indexed citations

17.

Freeman, Kevin W., et al.. (1998). Synthetic activation of caspases: Artificial death switches. Proceedings of the National Academy of Sciences. 95(7). 3655–3660. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact